CRYSTALLINE FORM OF AZALACTAM COMPOUND

    公开(公告)号:US20240409559A1

    公开(公告)日:2024-12-12

    申请号:US18698272

    申请日:2022-10-04

    Applicant: PFIZER INC.

    Abstract: This disclosure relates to a crystalline form of 4-[(1R)-1-aminopropyl]-2-{6-[(5S)-5-methyl-6,7-dihydro-5H-pyrro-lo[2,1-c][1,2,4]triazol-3-yl]pyridin-2-yl}-6-[(2R)-2-methylpyrrolidin-1-yl]-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin- 1-one (PF-07265028) free base and method of making thereof. The disclosure also relates to pharmaceutical compositions comprising this crystalline form, and to methods of using the crystalline form and such compositions for the treatment of abnormal cell growth, such as cancer, in a mammal.

Patent Agency Ranking